Healthcare data analytics company Health Catalyst (NASDAQ:HCAT) will be reporting results this Monday after market hours. Here’s what you need to know.
Health Catalyst met analysts’ revenue expectations last quarter, reporting revenues of $80.72 million, up 6.3% year on year. It was a slower quarter for the company, with full-year revenue guidance missing analysts’ expectations significantly and revenue guidance for next quarter missing analysts’ expectations significantly.
Is Health Catalyst a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, analysts are expecting Health Catalyst’s revenue to decline 1.8% year on year to $75.01 million, a reversal from the 3.5% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.07 per share.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Health Catalyst has only missed Wall Street’s revenue estimates once over the last two years, exceeding top-line expectations by 0.6% on average.
Looking at Health Catalyst’s peers in the data analytics segment, some have already reported their Q3 results, giving us a hint as to what we can expect. Strategy delivered year-on-year revenue growth of 10.9%, beating analysts’ expectations by 9.1%, and Palantir Technologies reported revenues up 62.8%, topping estimates by 8%. Strategy traded up 6% following the results while Palantir Technologies was down 8.1%.
Read our full analysis of Strategy’s results here and Palantir Technologies’s results here.
Investors in the data analytics segment have had steady hands going into earnings, with share prices flat over the last month. Health Catalyst is up 6.8% during the same time and is heading into earnings with an average analyst price target of $4.33 (compared to the current share price of $2.83).
The biggest winners—Microsoft, Alphabet, Coca-Cola, Monster Beverage—were all riding powerful megatrends before Wall Street caught on. We’ve just identified an under-the-radar profitable growth stock positioned at the center of the AI boom. Get it FREE here before the crowd discovers it. GO HERE NOW.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.